+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
THYROCARE

Thyrocare Technologies Share Price

₹498.25 +10.25 (2.1%)
45.45% Gain from 52W Low

13 Nov, 2026 3:57 PM (IST)

Thyrocare Technologies live price: ₹498.25. It opened at ₹488 vs previous close ₹488; intraday high/low: ₹500/₹487. The 50 & 200 DMA stand at ₹513.50/₹497.80.

Thyrocare Technologies Performance

  • Today's Low
  • ₹487
  • Today's High
  • ₹500
  • 52 Week Low
  • ₹343
  • 52 Week High
  • ₹662
  • Open Price₹488
  • Previous Close₹488
  • Volume234,907
  • 50 DMA₹513.50
  • 100 DMA₹519.80
  • 200 DMA₹497.80

Thyrocare Technologies Chart

Investment Returns

  • Over 1 Month -3.23%
  • Over 3 Month -22.51%
  • Over 6 Month + 4.89%
  • Over 1 Year + 6.82%

Smart Investing Starts Here Start SIP with Thyrocare Technologies for Steady Growth!

Invest Now

Thyrocare Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 55.1
  • PEG Ratio
  • 4.3
  • Market Cap Cr
  • 7,940
  • P/B Ratio
  • 12.5
  • Average True Range
  • 21.2
  • EPS
  • 9
  • Dividend Yield
  • 1.4
  • MACD Signal
  • -8.2
  • RSI
  • 46.53
  • MFI
  • 31.19

Latest Stock News Updates

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Please find the enclosed announcement.

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Change in Management

Please find the enclosed intimation.

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Please find attached the Earnings Call Transcript held on October 29, 2026

Thyrocare Technologies Financials

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹498.25
+ 10.25 (2.1%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹492.40
  • 50 Day
  • ₹513.50
  • 100 Day
  • ₹519.80
  • 200 Day
  • ₹497.80

Resistance and Support

495.18 Pivot Speed
  • R3 503.00
  • R2 497.90
  • R1 493.00
  • S1 482.90
  • S2 477.80
  • S3 472.90

Thyrocare Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-29 Quarterly Results
2026-07-23 Quarterly Results
2026-05-07 Audited Results & Final Dividend
2026-01-28 Quarterly Results
2025-10-14 Qtr Results, Int. Dividend & Bonus issue
Date Purpose Remarks
2026-06-23 FINAL Rs.7.00 per share(70%)Final Dividend
2025-10-24 INTERIM Rs.7.00 per share(70%)Interim Dividend
2025-07-25 FINAL Rs.21.00 per share(210%)Final Dividend
2024-08-16 FINAL Rs.18.00 per share(180%)Final Dividend
2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
View Thyrocare Technologies Dividend History Arrow
Date Purpose Remarks
2025-11-28 Bonus Bonus issue of equity shares in the ratio of 2:1 of Rs. 10/-.

Thyrocare Technologies Shareholding Pattern

51.02%
22.91%
13.69%
9.37%
3.01%

About Thyrocare Technologies

Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients. View More
  • NSE Symbol
  • THYROCARE
  • BSE Symbol
  • 539871
  • Chairman.,Executive Director,Managing Director,Chief Executive Officer
  • Rahul Guha
  • ISIN
  • INE594H01019

Similar Stocks to Thyrocare Technologies

Thyrocare Technologies FAQs

Thyrocare Technologies share price is ₹498 As on 13 November, 2026 | 16:20

The Market Cap of Thyrocare Technologies is ₹7940.1 Cr As on 13 November, 2026 | 16:20

The P/E ratio of Thyrocare Technologies is 55.1 As on 13 November, 2026 | 16:20

The PB ratio of Thyrocare Technologies is 12.5 As on 13 November, 2026 | 16:20

The 52 week High & Low of Thyrocare Technologies is ₹662/₹342.6 respectively As on 13 November, 2026 | 16:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23